Thermal Stability of Active Ingredients

Precise Material Characterization for Active Pharmaceutical Ingredients, Formulations, and Drug Development

The thermal stability of active pharmaceutical ingredients is a critical factor in the efficacy, safety, and shelf life of drugs. Even minor temperature fluctuations can cause physical or chemical changes that affect the solubility, bioavailability, or stability of an active ingredient.

Thermal analysis methods enable the precise study of melting behavior, glass transitions, crystallization, polymorphism, and thermal decomposition. They provide important information for the development of new formulations, the selection of suitable manufacturing processes, and the definition of optimal storage and transport conditions.

LINSEIS analytical instruments can be used to characterize active pharmaceutical ingredients and formulations throughout the entire development process—from early-stage drug development to quality control of finished pharmaceutical products.

Relevant Questions

  • What are the temperature limits for the active ingredient?
  • When does thermal decomposition begin?
  • What polymorphic forms are present?
  • How do excipients affect thermal stability?
  • What melting and crystallization processes occur?
  • How do amorphous formulations change during storage?
  • Which manufacturing parameters ensure maximum stability?
  • How can active ingredients be optimized for storage and transport?

Relevant Material and Process Parameters

Parameter Meaning
Melting Temperature Identification and Purity Assessment of Active Pharmaceutical Ingredients
Glass Transition Temperature (Tg) Stability of amorphous formulations
Crystallization Behavior Evaluation of Storage, Processing, and Product Quality
Polymorphism Distinguishing Between Different Crystal Forms of an Active Ingredient
Thermal Stability Resistance to Temperature Stress
Decomposition temperature Onset of thermal degradation processes
Mass Change Loss of moisture, solvent residues, and thermal decomposition
Heat Capacity (Cp) Characterization of Thermal Material Properties

Measurement Methods for the Thermal Stability of Active Ingredients

Differential Scanning Calorimetry (DSC)

Determination of thermal transitions in active pharmaceutical ingredients and formulations.

Analysis of

  • Melting point
  • Glass transition
  • Crystallization
  • Polymorphism
  • Heat Capacity

Typical Applications

  • APIs
  • Tablets
  • Capsules
  • Ambiguous Phrases
  • Quality Control

Thermogravimetry (TGA)

Analysis of mass changes and thermal decomposition of pharmaceutical materials.

Analysis of

  • Moisture content
  • Solvent residues
  • Thermal decomposition
  • Mass loss
  • Thermal stability

Typical Applications

  • Active Ingredients
  • Excipients
  • Granules
  • Powder
  • Wording

Simultaneous Thermal Analysis (STA)

Simultaneous investigation of thermal effects and changes in mass.

Analysis of

  • Melting Processes
  • Thermal stability
  • Mass change
  • Decomposition
  • Phase transitions

Typical Applications

  • Pharmaceutical Formulations
  • APIs
  • Excipients
  • Research & Development
  • Quality Control

Gravimetric Sorption Analysis (GSA)

Highly sensitive analysis of minute thermal effects and changes in stability.

Analysis of

  • Heat of reaction
  • Changes in Stability
  • Long-term behavior
  • Comparison of Wording
  • Thermodynamic Processes

Typical Applications

  • Drug Development
  • Stability Studies
  • Wording
  • Quality Control
  • Research

Recommended Measuring Instruments for Aging & Shelf Life

Case Study: Thermal Characterization of Active Pharmaceutical Ingredients

Thermal Stability of Nickel(II) Schiff Base Complexes

STA measurements using the LINSEIS STA L82 show the temperature-dependent decomposition and stability behavior of various nickel(II) Schiff base complexes. The measurement results identify characteristic multistage decomposition processes and provide valuable insights into thermal stability, material characterization, and the development of functional coordination compounds for pharmaceutical and catalytic applications. Download the white paper to learn more about the complete measurement setup, simultaneous thermal analysis, and the interpretation of the measurement results.

Why Analyzing the Thermal Stability of Active Ingredients Is Critical

The thermal properties of an active ingredient influence nearly every stage of pharmaceutical development—from formulation development through production to storage and transport. Early thermoanalytical characterization helps identify stability issues and determine appropriate measures for product optimization.

The combination of modern analytical methods makes it possible to:

  • Determination of Melting and Glass Transitions
  • Analysis of Polymorphic Crystal Forms
  • Investigation of Crystallization Processes
  • Assessment of Thermal Stability
  • Determination of Moisture and Solvent Content
  • Optimization of Pharmaceutical Formulations
  • Support for Quality Control and Stability Studies

Applications – Pharmaceuticals, Food & Life Sciences

FAQ – Thermal Stability of Active Ingredients

Why is the thermal stability of an active ingredient so important?

Thermal stability affects the efficacy, shelf life, and safety of a drug. Thermal analyses help identify critical temperatures for manufacturing, storage, and transport at an early stage.

Many active ingredients can exist in different crystalline forms. These forms differ in terms of solubility, bioavailability, stability, and manufacturability. DSC is one of the most important methods for identifying such polymorphic forms.

For amorphous active ingredients and formulations, the glass transition affects storage stability and the risk of subsequent crystallization. Determining it is therefore an important part of modern stability studies.

DSC, TGA, STA, and microcalorimetry complement each other perfectly. While DSC analyzes thermal transitions, TGA determines mass loss and decomposition. STA combines both types of information in a single measurement, and microcalorimetry detects minute heat effects and changes in stability.

The measurement systems are suitable for active pharmaceutical ingredients (APIs), excipients, tablets, capsules, powders, granules, amorphous formulations, and other pharmaceutical and biotechnology products.

It provides precise information on melting behavior, crystallization, polymorphism, and thermal stability. This enables formulations to be optimized in a targeted manner, manufacturing processes to be adjusted, and product quality to be ensured over the long term.